MSD's new drug combination shows promise in HIV-1 treatment, aiming to offset potential losses from Keytruda's patent ...

Texas has the second-highest population of LGBTQ people in the country, with 1.1 million of its residents identifying at ...

The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

VIR-5818 is under clinical development by Vir Biotechnology and currently in Phase II for Metastatic Breast Cancer.

Vancouver's Joe Average was an artist, advocate and activist whose bright, multicoloured images were as multi-faceted as his ...

Various animal species suffer from STIs similar to humans, such as syphilis in rabbits and HIV-like viruses in chimps and ...

Capsaicin is under clinical development by Grunenthal and currently in Phase III for Chemotherapy Induced Peripheral Neuropathy.

British teenager Marcus Fakana is facing a year in Dubai’s Al Awir prison, where inmates have reported ‘torturous’ and ‘hellish’ conditions for having sex with a holiday romance. The 18-year-old was ...

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.

Victoria-born artist Joe Average, whose award-winning work could be seen on canvases, posters, coins, stamps, murals and ...

An addict with HIV and hepatitis spat at and assaulted hospital and emergency staff who were trying to help him after a suspected cardiac arrest, a court has heard. Paul Simper, 44, was found "slumped ...